Standout Papers
- The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment (2018)
- Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)
Immediate Impact
6 from Science/Nature 62 standout
Citing Papers
Sociodemographic biases in medical decision making by large language models
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Victoria Blinder being referenced
Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC).
2019
Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Victoria Blinder | 1171 | 1312 | 121 | 463 | 78 | 2.6k | |
| William Lawrence | 1122 | 1099 | 169 | 487 | 67 | 3.7k | |
| Chunyu Li | 1189 | 1079 | 82 | 384 | 80 | 2.4k | |
| Jingxuan Zhao | 876 | 1135 | 129 | 341 | 106 | 2.5k | |
| Matthew P. Banegas | 953 | 1861 | 90 | 545 | 83 | 2.7k | |
| Christopher S. Lathan | 1427 | 745 | 240 | 1067 | 86 | 3.9k | |
| Reginald Tucker‐Seeley | 566 | 1137 | 27 | 595 | 66 | 2.7k | |
| Bruce Fireman | 792 | 642 | 119 | 291 | 41 | 3.2k | |
| Lydia E. Pace | 1080 | 385 | 216 | 491 | 96 | 2.2k | |
| Neetu Chawla | 877 | 633 | 57 | 452 | 77 | 2.4k | |
| Laura‐Mae Baldwin | 677 | 648 | 103 | 488 | 101 | 2.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...